{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:45:35Z","timestamp":1787845535910,"version":"build-2784847793"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:00:00Z","timestamp":1643241600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003969","name":"Ministry of Health and Medical Education of Iran","doi-asserted-by":"crossref","award":["700\/1918"],"award-info":[{"award-number":["700\/1918"]}],"id":[{"id":"10.13039\/501100003969","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>The PERSIAN Kavar cohort study (PKCS) aims to investigate the prevalence, trends, and relevant prognostic risk factors of non-communicable diseases in participants aged 35\u201370 years living in the urban area of Kavar County. Kavar County is located at the center of Fars province in the southwest of Iran. Overall, 5236 adults aged 35\u201370 years old were invited to participate in the PKCS. From whom, 4997 people comprising 2419 men and 2578 women met the inclusion criteria and were recruited in the study (participation rate: 95.4%). This study is aimed to follow participants for at least 10 years; it is designed to perform all procedures similar to the primary phase including biological sampling, laboratory tests, physical examinations, and collecting general, nutritional, and medical data at the 5<jats:sup>th<\/jats:sup> and 10<jats:sup>th<\/jats:sup> years of follow-up. In addition, participants are annually followed-up by phone to acquire data on the history of hospitalization, any major diagnosis or death. At the enrollment phase, trained interviewers were responsible for obtaining general, nutritional, and medical data utilizing a 482-item questionnaire. The results of the baseline phase of this study show that the overweight category was the most prevalent BMI category among the registered participants (n = 2005, 40.14%). Also, almost one-third of Kavar adult population suffered from metabolic syndrome at the baseline phase (n = 1664, 33.30%). The rate of eighteen-month follow-up response was 100% in the PKCS. Hypertension (n = 116, 2.32%), cardiovascular outcomes (n = 33, 0.66%), and diabetes (n = 32, 0.64%) were the most prevalent new-onset NCDs during eighteen months of follow-up in the participants.<\/jats:p>","DOI":"10.1371\/journal.pone.0260227","type":"journal-article","created":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T18:32:21Z","timestamp":1643308341000},"page":"e0260227","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":20,"title":["Alarm of non-communicable disease in Iran: Kavar cohort profile, baseline and 18-month follow up results from a prospective population-based study in urban area"],"prefix":"10.1371","volume":"17","author":[{"given":"Ali Reza","family":"Safarpour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza","family":"Fattahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramin","family":"Niknam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firoozeh","family":"Tarkesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahid","family":"Mohammadkarimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrokh Sadeghi","family":"Boogar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Abbasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firoozeh","family":"Abtahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gholam Reza","family":"Sivandzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fardad","family":"Ejtehadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Afshar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Ali","family":"Shamsnia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4007-6160","authenticated-orcid":true,"given":"Nasim","family":"Niknejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,1,27]]},"reference":[{"issue":"11","key":"pone.0260227.ref001","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/1469-0691.12021","article-title":"Infectious diseases in Iran: a bird\u2019s eye view","volume":"18","author":"M Askarian","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"pone.0260227.ref002","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.1002\/hpm.1105","article-title":"Weaknesses and challenges of primary healthcare system in Iran: a review.","volume":"27","author":"MN Moghadam","year":"2012","journal-title":"Int J Health Plann Manage"},{"issue":"9963","key":"pone.0260227.ref003","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(14)61682-2","article-title":"Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"385","author":"GBD Mortality","year":"2015","journal-title":"Lancet"},{"key":"pone.0260227.ref004","unstructured":"WHO. Noncommunicable diseases; 2018 [internet]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/noncommunicable-diseases."},{"issue":"2","key":"pone.0260227.ref005","first-page":"87","article-title":"The costs of disease burden in Iran.","volume":"3","author":"E Abbasian","year":"2015","journal-title":"Chronic Diseases Journal"},{"key":"pone.0260227.ref006","unstructured":"WHO. Noncommunicable Diseases (NCD) Country Profiles- Iran; 2018 [internet]. Available from: https:\/\/www.who.int\/nmh\/countries\/2018\/irn_en.pdf."},{"issue":"12","key":"pone.0260227.ref007","doi-asserted-by":"crossref","first-page":"e009597","DOI":"10.1136\/bmjopen-2015-009597","article-title":"Bushehr Elderly Health (BEH) Programme, phase I (cardiovascular system).","volume":"5","author":"A Ostovar","year":"2015","journal-title":"BMJ open"},{"issue":"3","key":"pone.0260227.ref008","first-page":"146","article-title":"National and sub-national burden of chronic diseases attributable to lifestyle risk factors in Iran 1990\u20132013; study protocol.","volume":"17","author":"A Ghasemian","year":"2014","journal-title":"Arch Iran Med."},{"issue":"1","key":"pone.0260227.ref009","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1186\/s12889-019-7715-z","article-title":"Socioeconomic gradient in physical activity: findings from the PERSIAN cohort study.","volume":"19","author":"AK Karyani","year":"2019","journal-title":"BMC public health."},{"issue":"3","key":"pone.0260227.ref010","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00038-016-0848-2","article-title":"Pars cohort study of non-communicable diseases in Iran: protocol and preliminary results.","volume":"62","author":"A Gandomkar","year":"2017","journal-title":"Int J Public Health"},{"issue":"1","key":"pone.0260227.ref011","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/ije\/dyp161","article-title":"Cohort Profile: The Golestan Cohort Study\u2014a prospective study of oesophageal cancer in northern Iran","volume":"39","author":"A Pourshams","year":"2010","journal-title":"Int J Epidemiol"},{"issue":"4","key":"pone.0260227.ref012","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1093\/ije\/dyp195","article-title":"Socio-economic status and oesophageal cancer: results from a population-based case-control study in a high-risk area","volume":"38","author":"F Islami","year":"2009","journal-title":"Int J Epidemiol"},{"issue":"4","key":"pone.0260227.ref013","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/aje\/kwx314","article-title":"Prospective Epidemiological Research Studies in Iran (the PERSIAN Cohort Study): Rationale, Objectives, and Design.","volume":"187","author":"H Poustchi","year":"2018","journal-title":"Am J Epidemiol"},{"issue":"1","key":"pone.0260227.ref014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12889-018-5364-2","article-title":"The protocol of a population-based prospective cohort study in southwest of Iran to analyze common non-communicable diseases: Shahrekord cohort study.","volume":"18","author":"A Khaledifar","year":"2018","journal-title":"BMC Public Health"},{"issue":"2","key":"pone.0260227.ref015","doi-asserted-by":"crossref","first-page":"131","DOI":"10.15171\/mejdd.2016.18","article-title":"The prevalence of metabolic syndrome in non-alcoholic fatty liver disease; a population-based study","volume":"8","author":"MR Fattahi","year":"2016","journal-title":"Middle East J Dig Dis"},{"key":"pone.0260227.ref016","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.2147\/DMSO.S246949","article-title":"Association Between Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome with Gallstone Disease, South Iran: A Population-Based Study.","volume":"13","author":"M Sepehrimanesh","year":"2020","journal-title":"Diabetes Metab Syndr Obes."},{"key":"pone.0260227.ref017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12889-020-08809-z","article-title":"Association between dyslipidemia and blood lipids concentration with smoking habits in the Kurdish population of Iran","volume":"20","author":"M Moradinazar","year":"2020","journal-title":"BMC Public Health"},{"key":"pone.0260227.ref018","volume-title":"National health and nutrition examination survey (nhanes): Anthropometry procedures manual","author":"Control CfD, Prevention","year":"2007"},{"issue":"1","key":"pone.0260227.ref019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12889-020-8322-8","article-title":"Socioeconomic-related inequalities in overweight and obesity: findings from the PERSIAN cohort study.","volume":"20","author":"F Najafi","year":"2020","journal-title":"BMC public health."},{"key":"pone.0260227.ref020","first-page":"78","article-title":"Socioeconomic inequality in noncommunicable diseases: Results from a baseline Persian cohort study.","volume":"35","author":"M Sharafi","year":"2021","journal-title":"Med j Islam Repub Iran"},{"issue":"4","key":"pone.0260227.ref021","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/aje\/kwx314","article-title":"Prospective epidemiological research studies in Iran (the PERSIAN Cohort Study): rationale, objectives, and design.","volume":"187","author":"H Poustchi","year":"2018","journal-title":"Am J Epidemiol"},{"issue":"2","key":"pone.0260227.ref022","doi-asserted-by":"crossref","first-page":"150","DOI":"10.2188\/jea.JE20090083","article-title":"Reproducibility and relative validity of food group intake in a food frequency questionnaire developed for the Tehran Lipid and Glucose Study.","volume":"20","author":"FH Esfahani","year":"2010","journal-title":"J Epidemiol."},{"key":"pone.0260227.ref023","first-page":"2486","article-title":"Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III).","volume-title":"Jama","author":"Expert Panel on Detection E","year":"2001"},{"key":"pone.0260227.ref024","unstructured":"WHO W. ICD-10 Version: 2016; 2016 [internet]. Available from: http:\/\/apps.who.int\/classifications\/icd10\/browse\/2016\/en#\/N17."},{"key":"pone.0260227.ref025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13011-020-00279-1","article-title":"Prevalence of drug use, alcohol consumption, cigarette smoking and measure of socioeconomic-related inequalities of drug use among Iranian people: findings from a national survey.","volume":"15","author":"M Moradinazar","year":"2020","journal-title":"Subst Abuse Treat Prev Policy."},{"issue":"10184","key":"pone.0260227.ref026","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/S0140-6736(18)33197-0","article-title":"Iran in transition","volume":"393","author":"G Danaei","year":"2019","journal-title":"The Lancet"},{"issue":"3","key":"pone.0260227.ref027","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/ije\/dyy296","article-title":"Cohort Profile: Ravansar Non-Communicable Disease cohort study: the first cohort study in a Kurdish population.","volume":"48","author":"Y Pasdar","year":"2019","journal-title":"Int J Epidemiol."},{"issue":"1","key":"pone.0260227.ref028","first-page":"39","article-title":"The PERSIAN Guilan cohort study (PGCS).","volume":"22","author":"F Mansour-Ghanaei","year":"2019","journal-title":"Arch Iran Med."},{"key":"pone.0260227.ref029","first-page":"141","article-title":"Cohort profile: The Hoveyzeh Cohort Study (HCS): A prospective population-based study on non-communicable diseases in an Arab community of Southwest Iran.","volume":"34","author":"B Cheraghian","year":"2020","journal-title":"Med j Islam Repub Iran"},{"issue":"2","key":"pone.0260227.ref030","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10654-020-00668-7","article-title":"The profile of Rafsanjan cohort study","volume":"36","author":"H Hakimi","year":"2021","journal-title":"Eur J Epidemiol"},{"issue":"6","key":"pone.0260227.ref031","first-page":"279","article-title":"Tabari cohort profile and preliminary results in urban areas and mountainous regions of Mazandaran, Iran.","volume":"22","author":"M Kheradmand","year":"2019","journal-title":"Arch Iran Med"},{"issue":"3","key":"pone.0260227.ref032","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00038-016-0848-2","article-title":"Pars cohort study of non-communicable diseases in Iran: protocol and preliminary results.","volume":"62","author":"A Gandomkar","year":"2017","journal-title":"Int J Public Health"},{"issue":"5","key":"pone.0260227.ref033","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/dar.13093","article-title":"Alcohol consumption in Iran: a systematic review and meta\u2010analysis of the literature","volume":"39","author":"M Chegeni","year":"2020","journal-title":"Drug Alcohol Rev"},{"key":"pone.0260227.ref034","doi-asserted-by":"crossref","first-page":"943162","DOI":"10.1155\/2014\/943162","article-title":"A comprehensive review on metabolic syndrome.","volume":"2014","author":"J. Kaur","year":"2014","journal-title":"Cardiol Res Pract"},{"issue":"3","key":"pone.0260227.ref035","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.cegh.2020.01.001","article-title":"Prevalence of metabolic syndrome and its components among a population-based study in south of Iran, PERSIAN Kharameh cohort study.","volume":"8","author":"H-A Nikbakht","year":"2020","journal-title":"Clin Epidemiology Glob Health"},{"key":"pone.0260227.ref036","doi-asserted-by":"crossref","first-page":"64","DOI":"10.4103\/ijpvm.IJPVM_489_18","article-title":"Prevalence and incidence of metabolic syndrome in Iran: A systematic review and meta-analysis.","volume":"11","author":"A Fatahi","year":"2020","journal-title":"Int J Prev Med"},{"issue":"2","key":"pone.0260227.ref037","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.dsx.2017.11.004","article-title":"Prevalence of metabolic syndrome in Middle-East countries: Meta-analysis of cross-sectional studies","volume":"12","author":"A Ansarimoghaddam","year":"2018","journal-title":"Diabetes Metab Syndr"},{"issue":"4","key":"pone.0260227.ref038","first-page":"473","article-title":"The prevalence of metabolic syndrome in Iran: a systematic review and meta-analysis.","volume":"47","author":"S Mazloomzadeh","year":"2018","journal-title":"Iran J Public Health"},{"issue":"1","key":"pone.0260227.ref039","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000075304","article-title":"The association of metabolic disorders with the metabolic syndrome is different in men and women.","volume":"48","author":"J Dallongeville","year":"2004","journal-title":"Ann Nutr Metab"},{"issue":"10","key":"pone.0260227.ref040","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/ncpendmet0616","article-title":"The metabolic syndrome in women.","volume":"3","author":"R Bentley-Lewis","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"2","key":"pone.0260227.ref041","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2174\/1573402115666190118142818","article-title":"Prevalence of HTN in Iran: Meta-analysis of Published Studies in 2004\u20132018.","volume":"15","author":"MJ Oori","year":"2019","journal-title":"Curr Hypertens Rev."},{"issue":"3","key":"pone.0260227.ref042","doi-asserted-by":"crossref","first-page":"591","DOI":"10.26719\/2009.15.3.591","article-title":"Prevalence of type 2 diabetes in the Islamic Republic of Iran: systematic review and meta-analysis","volume":"15","author":"A Haghdoost","year":"2009","journal-title":"East Mediterr Health J"},{"key":"pone.0260227.ref043","doi-asserted-by":"crossref","first-page":"107843","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas","volume":"157","author":"P Saeedi","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"pone.0260227.ref044","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41581-019-0244-2","article-title":"The global epidemiology of hypertension","volume":"16","author":"KT Mills","year":"2020","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"pone.0260227.ref045","article-title":"Sex-specific incidence rates and risk factors for hypertension during 13 years of follow-up: The tehran lipid and glucose study.","volume":"15","author":"S Asgari","year":"2020","journal-title":"Global heart."},{"issue":"10","key":"pone.0260227.ref046","doi-asserted-by":"crossref","first-page":"107652","DOI":"10.1016\/j.jdiacomp.2020.107652","article-title":"Incidence of hypertension among Asian Indians: 10 year follow up of the Chennai Urban Rural Epidemiology Study (CURES-153).","volume":"34","author":"V Mohan","year":"2020","journal-title":"J Diabetes Complications."},{"key":"pone.0260227.ref047","first-page":"12","volume-title":"National diabetes statistics report, 2020.","author":"Control CfD, Prevention","year":"2020"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0260227","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T18:33:07Z","timestamp":1643308387000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0260227"}},"subtitle":[],"editor":[{"given":"Hassan","family":"Ashktorab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,1,27]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0260227","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,27]]}}}